GlaxoSmithKline | GSK - 貿易債務者





貿易債務者 変化する 日付
AbbVie USD 13.82B 1.34B 2026-06
Alcon AG USD 2.1B 90M 2026-06
Almirall EUR 196.15M 20.22M 2026-06
Amgen USD 10.35B 126M 2026-09
argenx SE USD 2.01B 352.94M 2026-06
AstraZeneca USD 18.87B 11M 2026-09
Bayer EUR 17.41B 1.29B 2026-09
Biogen USD 2.38B 15.8M 2026-09
Bristol-Myers Squibb USD 12.85B 976M 2026-09
Eli Lilly USD 23.48B 2.3B 2026-06
Fresenius EUR 4.89B 250M 2026-09
Fresenius Medical Care EUR 3.47B 250.22M 2026-06
Genmab DKK 1.22B 192M 2026-06
Gilead Sciences USD 5.06B 314M 2026-06
GlaxoSmithKline GBP 8.52B 451M 2026-09
Glaxosmithkline GBP 11.31B 814.23M 2026-09
GRIFOLS EUR 1.08B 110M 2026-09
Hikma Pharmaceutical USD 1.08B 27M 2025-12
Lakefront Biotherapeutics EUR 149.47M 95.44M 2026-06
Lonza CHF 1.78B 55M 2025-12
Merck EUR 4.95B 139M 2026-06
Merck USD 12.56B 354M 2026-06
Novartis USD 9.96B 109M 2026-09
Novo Nordisk DKK 114.94B 8.68B 2026-06
Orion EUR 543.8M 155.8M 2026-06
Pfizer USD 17.57B 1.38B 2026-09
Philips EUR 3.6B 70M 2026-06
Recordati EUR 778.71M 13.98M 2026-06
Regeneron Pharmaceuticals USD 6.57B 834.4M 2026-06
Roche Holding CHF 13.34B 1.44B 2026-06
Sanofi EUR 326M 166M 2026-09
Smith & Nephew USD 1.52B 36M 2026-06
UCB EUR 1.97B 54M 2025-12